Human FLT3 (Receptor-Type Tyrosine-Protein Kinase Flt3) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-06409P

SDS-PAGE analysis of Human FLT3 (Receptor-Type Tyrosine-Protein Kinase Flt3) - Recombinant Protein, CAT# BLT-06409P, showing >95% purity under 15% SDS-PAGE (Reduced)
Human FLT3 (Receptor-Type Tyrosine-Protein Kinase Flt3) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-06409P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human FLT-3 / CD135 / FLK-2 (FLT3) Protein |
Product Overview | This recombinant human FLT-3 / CD135 / FLK-2 (FLT3) protein includes amino acids 1-541aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | P36888 |
Recommended Name | Receptor-type tyrosine-protein kinase FLT3 |
Gene Name | FLT3 |
Synonyms | CD135;FLK-2;FLK2;STK1 |
Species | Human |
Predicted Molecular Mass | 59.7 kDa |
Expression System | Mammalian Cell |
Expression Range | 1-541aa |
Tag | C-His |
Purity | >95% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Immunology |
Target Function | Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or STAT5B. Activation of wild-type FLT3 causes only marginal activation of STAT5A or STAT5B. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways. |
Subcellular Location | Membrane; Single-pass type I membrane protein. Endoplasmic reticulum lumen. Note=Constitutively activated mutant forms with internal tandem duplications are less efficiently transported to the cell surface and a significant proportion is retained in an immature form in the endoplasmic reticulum lumen. The activated kinase is rapidly targeted for degradation. |
Protein Family | Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily |
Associated Diseases | Leukemia, acute myelogenous (AML) |
Tissue Specificity | Detected in bone marrow, in hematopoietic stem cells, in myeloid progenitor cells and in granulocyte/macrophage progenitor cells (at protein level). Detected in bone marrow, liver, thymus, spleen and lymph node, and at low levels in kidney and pancreas. H |